159 related articles for article (PubMed ID: 37370182)
21. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of factors affecting survival rate in primary bone sarcomas with extremity and pelvis involvement.
Sofulu Ö; Erol B
Acta Orthop Traumatol Turc; 2020 May; 54(3):234-244. PubMed ID: 32544060
[TBL] [Abstract][Full Text] [Related]
23. Adjuvant chemotherapy for osteosarcoma may not increase survival after neoadjuvant chemotherapy and surgical resection.
Berend KR; Pietrobon R; Moore JO; Dibernardo L; Harrelson JM; Scully SP
J Surg Oncol; 2001 Nov; 78(3):162-70. PubMed ID: 11745799
[TBL] [Abstract][Full Text] [Related]
24. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
[TBL] [Abstract][Full Text] [Related]
25. Correlation between Prognostic Factors and the Histopathological Response to Neoadjuvant Chemotherapy in Osteosarcoma: A Retrospective Study.
Prabowo Y; Setiawan I; Kamal AF; Kodrat E; Labib Zufar ML
Int J Surg Oncol; 2021; 2021():8843325. PubMed ID: 33996154
[TBL] [Abstract][Full Text] [Related]
26. Lung and bone metastases patterns in osteosarcoma: Chemotherapy improves overall survival.
Tang L; Liu B
Medicine (Baltimore); 2023 Jan; 102(4):e32692. PubMed ID: 36705375
[TBL] [Abstract][Full Text] [Related]
27. Pulmonary metastases of stage IIB extremity osteosarcoma and subsequent pulmonary metastases.
Ward WG; Mikaelian K; Dorey F; Mirra JM; Sassoon A; Holmes EC; Eilber FR; Eckardt JJ
J Clin Oncol; 1994 Sep; 12(9):1849-58. PubMed ID: 8083708
[TBL] [Abstract][Full Text] [Related]
28. Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study.
Zhang C; Guo X; Xu Y; Han X; Cai J; Wang X; Wang G
Sao Paulo Med J; 2019; 137(5):423-429. PubMed ID: 31939567
[TBL] [Abstract][Full Text] [Related]
29. Osteosarcoma after the age of fifty: A clinicopathological study.
Tempelaere C; Biau D; Babinet A; Anract P
Eur J Surg Oncol; 2019 Jul; 45(7):1288-1292. PubMed ID: 31014986
[TBL] [Abstract][Full Text] [Related]
30. Prognosticating metastatic osteosarcoma treated with uniform chemotherapy protocol without high dose methotrexate and delayed metastasectomy: a single center experience of 102 patients.
Nataraj V; Rastogi S; Khan SA; Sharma MC; Agarwala S; Vishnubhatla S; Bakhshi S
Clin Transl Oncol; 2016 Sep; 18(9):937-44. PubMed ID: 26742936
[TBL] [Abstract][Full Text] [Related]
31. Elevated Expression of Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) Is Associated With a Poor Prognosis in Osteosarcoma.
Matsuda K; Miyoshi H; Hiraoka K; Hamada T; Nakashima K; Shiba N; Ohshima K
Clin Orthop Relat Res; 2018 Sep; 476(9):1848-1855. PubMed ID: 30024460
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Molecular Analysis of Pathologic Fracture-associated Osteosarcoma: MicroRNA profile Is Different and Correlates with Prognosis.
Lozano Calderón SA; Garbutt C; Kim J; Lietz CE; Chen YL; Bernstein K; Chebib I; Nielsen GP; Deshpande V; Rubio R; Wang YE; Quackenbush J; Delaney T; Raskin K; Schwab J; Cote G; Spentzos D
Clin Orthop Relat Res; 2019 Sep; 477(9):2114-2126. PubMed ID: 31389890
[TBL] [Abstract][Full Text] [Related]
33. Response to neoadjuvant chemotherapy and survival of children and adolescents with high-grade osteosarcoma treated based on the EURAMOS-1 protocol.
Suárez-Mattos A; Arroyave F; Infante AM; Narváez C; Soto C; Gómez L; Amaya-Nieto J
Bol Med Hosp Infant Mex; 2022; 79(1):17-25. PubMed ID: 35086129
[TBL] [Abstract][Full Text] [Related]
34. Long-term results after combined modality treatment for non-metastatic osteosarcoma.
Aparicio J; Segura A; Montalar J; Garcerá S; Oltra A; Santaballa A; Yuste A; Pastor M; Munárriz B
Med Oncol; 1999 Dec; 16(4):255-60. PubMed ID: 10618688
[TBL] [Abstract][Full Text] [Related]
35. The Treatment and Outcomes of Extraskeletal Osteosarcoma: Institutional Experience and Review of The Literature.
Nystrom LM; Reimer NB; Reith JD; Scarborough MT; Gibbs CP
Iowa Orthop J; 2016; 36():98-103. PubMed ID: 27528844
[TBL] [Abstract][Full Text] [Related]
36. Does neoadjuvant chemotherapy provide a survival benefit in maxillofacial osteosarcoma: A systematic review and pooled analysis.
Khadembaschi D; Jafri M; Praveen P; Parmar S; Breik O
Oral Oncol; 2022 Dec; 135():106133. PubMed ID: 36228524
[TBL] [Abstract][Full Text] [Related]
37. Predictors of the Survival of Primary and Secondary Older Osteosarcoma Patients.
Wang Z; Wu B; Zhou Y; Huang X; Pan W; Liu M; Yan X; Lin N; Ye Z
J Cancer; 2019; 10(19):4614-4622. PubMed ID: 31528225
[No Abstract] [Full Text] [Related]
38. The addition of the immunomodulator mifamurtide to adjuvant chemotherapy for early osteosarcoma: a retrospective analysis.
Kokkali S; Kotsantis I; Magou E; Sophia T; Kormas T; Diakoumis G; Spathas N; Psyrri A; Ardavanis A
Invest New Drugs; 2022 Jun; 40(3):668-675. PubMed ID: 35312944
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of prognostic factors in osteosarcoma adult patients, a single institution experience].
Adamkova Krakorova D; Vesely K; Zambo I; Tucek S; Tomasek J; Jureckova A; Janicek P; Cerny J; Pazourek L; Ondrusek S; Selingerova I
Klin Onkol; 2012; 25(5):346-58. PubMed ID: 23102196
[TBL] [Abstract][Full Text] [Related]
40. Pathological Fracture and Prognosis of High-Grade Osteosarcoma of the Extremities: An Analysis of 2,847 Consecutive Cooperative Osteosarcoma Study Group (COSS) Patients.
Kelley LM; Schlegel M; Hecker-Nolting S; Kevric M; Haller B; Rössig C; Reichardt P; Kager L; Kühne T; Gosheger G; Windhager R; Specht K; Rechl H; Tunn PU; Baumhoer D; Wirth T; Werner M; von Kalle T; Nathrath M; Burdach S; Bielack S; von Lüttichau I
J Clin Oncol; 2020 Mar; 38(8):823-833. PubMed ID: 31928458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
